Micturition, Neurogenic Bladder & Incontinence
Three nerves, four receptors and a pontine switch explain every way the bladder fails
Peripheral wiring of the bladder
| Pathway | Nerve and level | Receptor | Effect |
|---|---|---|---|
| Sympathetic (storage) | Hypogastric nerve, T10–L2 | β3 on detrusor; α1 on bladder neck and internal sphincter | Detrusor relaxes; internal sphincter closes |
| Parasympathetic (voiding) | Pelvic splanchnic nerves, S2–S4 | M3 (Gq → IP3 → Ca2+) on detrusor | Detrusor contracts; nitric oxide relaxes the outlet |
| Somatic (continence) | Pudendal nerve, S2–S4 (Onuf nucleus) | Nicotinic on striated muscle | External sphincter held closed voluntarily |
Storage. As the bladder fills, sympathetic norepinephrine on β3 receptors relaxes the detrusor, so pressure stays low while volume rises, and α1 receptors keep the bladder neck and internal sphincter shut. Pudendal output to the external sphincter, reinforced by the levator ani, adds voluntary continence during coughing and straining. α1-agonist decongestants such as pseudoephedrine can precipitate acute retention in men with BPH, whereas α1-blockers such as tamsulosin ease outflow.
Voiding. Parasympathetic acetylcholine contracts the detrusor through M3 receptors, nitric oxide relaxes the outlet, and pudendal firing stops so the external sphincter opens.
Central coordination
Bladder stretch travels in pelvic nerve afferents to the sacral cord and up to the periaqueductal gray, which relays fullness to the pontine micturition center. The pontine center is the switch that fires detrusor contraction and sphincter relaxation together, so the bladder empties completely at low pressure. The medial frontal cortex tonically inhibits it until voiding is appropriate. Frontal lesions (normal pressure hydrocephalus, tumors, stroke, dementia) remove that brake and cause urgency and urge incontinence. Normal pressure hydrocephalus pairs urinary urgency and incontinence with a magnetic gait and dementia, because enlarging ventricles stretch periventricular frontal fibers.
Neurogenic bladder by lesion level
| Level | Examples | Bladder behavior | Residual |
|---|---|---|---|
| Suprapontine | Stroke, dementia, Parkinson disease, NPH, frontal tumor | Uninhibited detrusor, coordinated sphincter; urge incontinence | Low |
| Suprasacral cord | Trauma, multiple sclerosis, transverse myelitis | Reflex overactive detrusor with detrusor-sphincter dyssynergia | Elevated, high pressure |
| Sacral or peripheral | Conus or cauda equina lesion, diabetic autonomic neuropathy, radical pelvic surgery | Atonic, large bladder with lost sensation; overflow | Large |
Spinal cord injury. Spinal shock first leaves an areflexic bladder in retention that needs catheterization. Over weeks to months, sacral reflexes return without pontine coordination, and the detrusor contracts against a simultaneously contracting external sphincter (detrusor-sphincter dyssynergia). High pressure and incomplete emptying cause vesicoureteral reflux, hydronephrosis, recurrent UTIs and CKD if unmanaged.
With lesions above T6, a distended bladder or blocked catheter can trigger autonomic dysreflexia: severe hypertension, pounding headache, flushing and sweating above the lesion and reflex bradycardia. Relieve the stimulus first.
Cauda equina and diabetes. Cauda equina compression (disc herniation, tumor) adds saddle anesthesia, loss of the anal wink and bulbocavernosus reflexes and bowel dysfunction. Diabetic autonomic neuropathy first dulls bladder sensation; the bladder overdistends and contractility fails.
Incontinence types and treatment
| Feature | Stress | Urge | Overflow |
|---|---|---|---|
| Mechanism | Urethral hypermobility or intrinsic sphincter deficiency | Detrusor overactivity | Outlet obstruction or underactive detrusor |
| Pattern | Small leaks with cough, sneeze or lifting; no urge | Sudden urge, then leakage; frequency, nocturia | Constant dribbling from a full bladder |
| Post-void residual | Normal | Normal | Large |
| Causes | Vaginal childbirth, obesity, menopause, prostatectomy | Idiopathic; neurologic disease; UTI, caffeine | BPH, urethral stricture, fecal impaction, diabetic neuropathy, anticholinergics, opioids |
| Treatment | Pelvic floor (Kegel) training, weight loss, pessary, midurethral sling | Bladder training, timed voiding, less caffeine and evening fluid; drugs below | Treat the cause; α1-blockers for BPH; intermittent catheterization; bethanechol |
Antimuscarinics. Oxybutynin, tolterodine, solifenacin, darifenacin and trospium block detrusor M3 receptors. Adverse effects are dry mouth, constipation, blurred vision, tachycardia and urinary retention, and they are avoided in narrow-angle glaucoma. In older adults the cumulative anticholinergic burden causes confusion and cognitive decline; oxybutynin is on the Beers list, whereas trospium, a charged quaternary amine, barely crosses the blood-brain barrier.
Other urge therapies. The β3 agonists mirabegron and vibegron relax the detrusor during filling without anticholinergic effects; mirabegron can raise blood pressure. Refractory cases receive intradetrusor onabotulinumtoxinA, which cleaves SNAP-25 and blocks acetylcholine release, at the risk of retention requiring self-catheterization.
Overflow therapy. Bethanechol, a cholinesterase-resistant muscarinic agonist, strengthens a hypotonic detrusor, and drugs that weaken contraction, especially anticholinergics, are stopped.
Bethanechol is contraindicated when retention stems from mechanical obstruction: a stronger contraction against a blocked outlet risks bladder injury.